Bank of New York Mellon »

Aclaris Therapeutics shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Aclaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aclaris Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aclaris Therapeutics by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2024-03-31 $289k 233k 1.24
2023-12-31 $297k 282k 1.05
2023-09-30 $1.7M 243k 6.85
2023-06-30 $2.5M 242k 10.37
2023-03-31 $1.9M 230k 8.09
2022-12-31 $3.6M 232k 15.75
2022-09-30 $4.0M 234k 16.95
2022-06-30 $2.8M 202k 13.96
2022-03-31 $3.2M 186k 17.23
2021-12-31 $2.7M 186k 14.54
2021-09-30 $3.3M 182k 18.01
2021-06-30 $2.4M 135k 17.58
2021-03-31 $2.8M 111k 25.19
2020-12-31 $677k 105k 6.47
2020-09-30 $281k 109k 2.57
2020-06-30 $166k 109k 1.52
2020-03-31 $228k 218k 1.05
2019-12-31 $415k 220k 1.89
2019-09-30 $134k 124k 1.08
2019-06-30 $360k 165k 2.18
2019-03-31 $1.2M 205k 5.98
2018-12-31 $1.5M 198k 7.39
2018-09-30 $6.1M 421k 14.52
2018-06-30 $8.4M 423k 19.97
2018-03-31 $6.9M 392k 17.52
2017-12-31 $6.7M 272k 24.67
2017-06-30 $2.4M 88k 27.10
2017-03-31 $2.6M 88k 29.83
2016-12-31 $3.1M 115k 27.13
2016-09-30 $1.2M 47k 25.64
2016-06-30 $653k 35k 18.51